Top Markets
#1 Resolv wstUSR Resolv wstUSR +114.61%
#2 Luxxcoin Luxxcoin +45.15%
#3 ResearchCoin ResearchCoin +21.62%
#4 Reactive Network Reactive Network +21.45%
#5 Layer3 Layer3 +19.67%
#6 Orderly Network Orderly Network +16.55%
#7 Aria.AI Aria.AI +12.61%
#8 Bitgert Bitgert +11.76%
#9 Lisk Bridged wstETH (Lisk) Lisk Bridged wstETH (Lisk) +9.32%
#10 KAITO KAITO +9.04%
Coin of the day
Resolv wstUSR Resolv wstUSR
Настройки
Язык
Pусский
Валюта
USD
Тема
CSL Limited CSL Limited

CSL Limited

CSL
Ранг среди акций #432
CSL Limited researches, develops, manufactures, markets, and distributes... CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plasma products and recombinants. This segment also conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The CSL Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and develops influenza related products. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.
Цена акции
$99.32
Рыночная капитализация
$48.20B
Изменение (1 день)
0.98%
Изменение (1 год)
-32.14%
Страна
AU
Торговля CSL Limited (CSL)

Категория

Healthcare
История дивидендной доходности для CSL Limited (CSL)
Дивидендная доходность (TTM) компании CSL Limited (тикер: CSL) на 2024-06-30 составляет: 1.35%
Средняя дивидендная доходность за последние 5 лет: 1.54%
История дивидендной доходности компании CSL Limited (CSL) с 2000 по 2026
Дивидендная доходность на конец каждого года (TTM)
Год Дивидендная доходность Изменить
2026 (TTM) 3.00% 59.57%
2025 1.88% 39.26%
2024 1.35% -25.41%
2023 1.81% 9.70%
2022 1.65% 66.67%
2021 0.99% 41.43%
2020 0.70% -39.13%
2019 1.15% 16.16%
2018 0.99% 2.06%
2017 0.97% -37.01%
2016 1.54% 18.46%
2015 1.30% -14.47%
2014 1.52% -7.88%
2013 1.65% -21.05%
2012 2.09% -19.62%
2011 2.60% 31.31%
2010 1.98% 47.76%
2009 1.34% 26.42%
2008 1.06% 23.26%
2007 0.86% -8.51%
2006 0.94% 28.77%
2005 0.73% 65.91%
2004 0.44% -76.84%
2003 1.90% 533.33%
2002 0.30% 15.38%
2001 0.26% -35.00%
2000 0.40% 0.00%
Дивидендная доходность (TTM) аналогичных компаний или конкурентов
Компания Дивидендная доходность Страна
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
4.14%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
0.46%
US
UCB SA UCB SA
UCB SA
UCB.BR
0.46%
BE
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL